ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siddiqui, S.
Right arrow Articles by Brightling, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siddiqui, S.
Right arrow Articles by Brightling, C. E.
Eur Respir J 2007; 30:1043-1056
Copyright ©ERS Journals Ltd 2007

Inflammatory cell microlocalisation and airway dysfunction: cause and effect?

S. Siddiqui, F. Hollins, S. Saha and C. E. Brightling

Institute for Lung Health, Dept of Infection, Inflammation and Immunity, University of Leicester, Leicester, UK.

CORRESPONDENCE: C. E. Brightling, Dept of Respiratory Medicine, University Hospitals of Leicester, Groby Road, Leicester, LE3 9QP, UK. Fax: 44 1162502787. E-mail: ceb17{at}le.ac.uk

Keywords: Asthma remodelling, cellular interactions, chronic obstructive pulmonary disease remodelling

Received: December 12, 2006
Accepted July 30, 2007

Airway inflammation is a critical feature of the airway diseases asthma and chronic obstructive pulmonary disease (COPD). There is emerging evidence that structural cells play a key role in the development and perpetuation of the inflammatory response and are pivotal in the development of the changes in the airway structures that lead to airway remodelling.

To date, little attention has been given to the localisation of inflammatory cells to airway structures or the potential interactions between these intimately located cells. However, it is likely that interactions between inflammatory and structural cells in the airway contribute enormously to the pathophysiology of asthma and COPD.

Indeed, recent evidence suggests that mast cells localised to the airway smooth muscle bundle may be important in the development of airway hyperresponsiveness in asthma.

In the present article, the authors aim to summarise: 1) the current understanding of which inflammatory cells locate to airway structures; 2) the proposed mechanisms that may be involved in mediating this microlocalisation; 3) the possible consequences of interactions between inflammatory and structural cells; and 4) the pressing need to investigate whether modulating these interactions is beneficial in asthma and chronic obstructive pulmonary disease.




This article has been cited by other articles:


Home page
ThoraxHome page
C K Andersson, M Mori, L Bjermer, C-G Lofdahl, and J S Erjefalt
Novel site-specific mast cell subpopulations in the human lung
Thorax, April 1, 2009; 64(4): 297 - 305.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Woodman, S. Siddiqui, G. Cruse, A. Sutcliffe, R. Saunders, D. Kaur, P. Bradding, and C. Brightling
Mast Cells Promote Airway Smooth Muscle Cell Differentiation via Autocrine Up-Regulation of TGF-{beta}1
J. Immunol., October 1, 2008; 181(7): 5001 - 5007.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.